PL374317A1 - Kompozycja zawierająca androgenowy 11beta-chlorowcosteroid i gestagen oraz męski środek antykoncepcyjny na podstawie tej kompozycji - Google Patents

Kompozycja zawierająca androgenowy 11beta-chlorowcosteroid i gestagen oraz męski środek antykoncepcyjny na podstawie tej kompozycji

Info

Publication number
PL374317A1
PL374317A1 PL03374317A PL37431703A PL374317A1 PL 374317 A1 PL374317 A1 PL 374317A1 PL 03374317 A PL03374317 A PL 03374317A PL 37431703 A PL37431703 A PL 37431703A PL 374317 A1 PL374317 A1 PL 374317A1
Authority
PL
Poland
Prior art keywords
composition
androgenous
11beta
composition containing
male contraceptive
Prior art date
Application number
PL03374317A
Other languages
English (en)
Inventor
Reinhard Nubbemeyer
Ursula-Friederike Habenicht
Rolf Bohlmann
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10234525A external-priority patent/DE10234525A1/de
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of PL374317A1 publication Critical patent/PL374317A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL03374317A 2002-07-25 2003-07-25 Kompozycja zawierająca androgenowy 11beta-chlorowcosteroid i gestagen oraz męski środek antykoncepcyjny na podstawie tej kompozycji PL374317A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10234525A DE10234525A1 (de) 2002-07-25 2002-07-25 Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung
US44940003P 2003-02-25 2003-02-25

Publications (1)

Publication Number Publication Date
PL374317A1 true PL374317A1 (pl) 2005-10-03

Family

ID=31189299

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03374317A PL374317A1 (pl) 2002-07-25 2003-07-25 Kompozycja zawierająca androgenowy 11beta-chlorowcosteroid i gestagen oraz męski środek antykoncepcyjny na podstawie tej kompozycji

Country Status (17)

Country Link
US (1) US20060100180A1 (pl)
EP (1) EP1524983B1 (pl)
JP (1) JP2006502997A (pl)
KR (1) KR20050025985A (pl)
CN (1) CN1671394A (pl)
AT (1) ATE382355T1 (pl)
AU (1) AU2003251636B2 (pl)
BR (1) BR0312922A (pl)
CA (1) CA2493207A1 (pl)
DE (1) DE50308933D1 (pl)
EC (1) ECSP055629A (pl)
ES (1) ES2299735T3 (pl)
HR (1) HRP20050173A2 (pl)
IL (1) IL166432A0 (pl)
MX (1) MXPA05001017A (pl)
PL (1) PL374317A1 (pl)
WO (1) WO2004011008A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10233723A1 (de) 2002-07-24 2004-02-12 Schering Ag Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene
NZ537871A (en) * 2002-07-24 2006-10-27 Schering Ag Microbiological processes for the production of 7 alpha-substituted 11 alpha-hydroxy steroids
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3714965A1 (de) * 1987-04-30 1988-11-10 Schering Ag 3-methylen-4-androsten-17-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE19650352A1 (de) * 1996-12-04 1998-07-30 Jenapharm Gmbh Oral wirksames Kombinationspräparat zur Kontrazeption für den Mann
US5952319A (en) * 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
DE19848303A1 (de) * 1998-10-14 2000-04-20 Schering Ag Kombination aus Gestagenen und Zuckern
MXPA02007675A (es) * 2000-02-15 2004-02-26 Schering Ag Formulacion anticonceptiva masculina que comprende noretisterona.
EP1216699A1 (de) * 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermalsystem enthaltend ein hochpotentes Gestagen
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
ECSP055629A (es) 2005-04-18
AU2003251636A1 (en) 2004-02-16
WO2004011008A1 (de) 2004-02-05
BR0312922A (pt) 2005-07-12
DE50308933D1 (de) 2008-02-14
MXPA05001017A (es) 2005-06-08
AU2003251636B2 (en) 2009-10-22
EP1524983A1 (de) 2005-04-27
US20060100180A1 (en) 2006-05-11
CN1671394A (zh) 2005-09-21
EP1524983B1 (de) 2008-01-02
ATE382355T1 (de) 2008-01-15
HRP20050173A2 (en) 2005-04-30
KR20050025985A (ko) 2005-03-14
ES2299735T3 (es) 2008-06-01
JP2006502997A (ja) 2006-01-26
IL166432A0 (en) 2006-01-15
CA2493207A1 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
PL374317A1 (pl) Kompozycja zawierająca androgenowy 11beta-chlorowcosteroid i gestagen oraz męski środek antykoncepcyjny na podstawie tej kompozycji
EE05282B1 (et) ™strogeeni-tsklodekstriini komplekside kompositsioonid
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
MY129450A (en) Pharmaceutical composition
MY138479A (en) 7alpha-hydroxyacetyl and 7alpha-hydroperoxyacetyl-substituted steroid compounds
DK1409021T3 (da) Formulering omfattende fulvestrant
AU2003255355A1 (en) Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
DE60201074D1 (en) Pyrazolopyridinderivate
AU2003267551A1 (en) Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
NO20050995L (no) Sammensetning inneholdende et androgent 11β- halogensteroid og et progestasjonelt hormon samt mannlig prevensjonsmiddel basert pa denne sammensetningen
PL1635843T3 (pl) Hormonalna terapia zastępcza i leczenie depresji obejmujące dienogest
EA200601030A1 (ru) 7α,17α-ЗАМЕЩЁННЫЕ 11β-ГАЛОГЕНОСТЕРОИДЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ПРИМЕНЕНИЕ И ФАРМАЦЕВТИЧЕСКИЙ ПРЕПАРАТ НА ИХ ОСНОВЕ
ATE377020T1 (de) Kristallines gamma-lacton der17beta-hydroxy-
AU2002326391A1 (en) Carvedilol polymorph
GB0128071D0 (en) Medicament
WO1996028154A3 (de) Verwendung von antiestrogenen zur männlichen fertilitätskontrolle
WO2003040316A3 (en) Selective elimination of cd52+ cells and uses thereof
姚晶晶 et al. My Happiest Day
GB0205327D0 (en) compounds
WO2005046566A3 (en) Stable gabapentin containing composition
MD2066F1 (en) ntihypertensive remedy
YU87302A (sh) Inhibitori 11-beta-hidroksi steroidne dehidrogenaze, tip 1
DK1365768T3 (da) Anvendelse af ER-beta-selektive antagonister som contraception.

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)